Alpha Tau Medical Ltd. (DRTS) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Jerusalem, Israel. The current CEO is Uzi Sofer.
DRTS has IPO date of 2021-03-08, 125 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $689.12M.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
